These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 7066357)
21. Catabolism of very low density lipoproteins in experimental nephrosis. Garber DW; Gottlieb BA; Marsh JB; Sparks CE J Clin Invest; 1984 Oct; 74(4):1375-83. PubMed ID: 6480830 [TBL] [Abstract][Full Text] [Related]
22. Fluvastatin, a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, suppresses very low-density lipoprotein secretion in puromycin aminonucleoside-nephrotic rats. Moritomo Y; Hirano T; Ebara T; Kurokawa M; Naito H; Furukawa S; Nagano S Nephron; 1994; 67(2):218-25. PubMed ID: 8072613 [TBL] [Abstract][Full Text] [Related]
23. Urinary excretion of apolipoproteins bound to HDL-like particles in rat nephrotic syndrome and their relation to plasma HDL. Shafrir E; Levy E; Deckelbaum R Nephron; 1990; 56(1):24-9. PubMed ID: 2234246 [TBL] [Abstract][Full Text] [Related]
24. Experimental nephrotic syndrome induced in the rat by puromycin aminonucleoside: hepatic synthesis of neutral lipids and phospholipids from 3H-water and 3H-palmitate. Gherardi E; Calandra S Lipids; 1980 Feb; 15(2):108-12. PubMed ID: 7374358 [No Abstract] [Full Text] [Related]
25. Alterations in proteoglycan metabolism in the nephrotic syndrome induced by the aminonucleoside of puromycin. Klein DJ; Dehnel PJ; Oegema TR; Brown DM Lab Invest; 1984 May; 50(5):543-51. PubMed ID: 6232422 [TBL] [Abstract][Full Text] [Related]
26. Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. I. The role of proteinuria, hypoproteinemia, and renin-angiotensin-aldosterone system on sodium retention. Pedraza-Chaverrí J; Cruz C; Ibarra-Rubio ME; Chávez MT; Calleja C; Tapia E; del Carmen Uribe M; Romero L; Peña JC Rev Invest Clin; 1990; 42(1):29-38. PubMed ID: 2236972 [TBL] [Abstract][Full Text] [Related]
27. Plantago asiatica L. Ameliorates Puromycin Aminonucleoside-Induced Nephrotic Syndrome by Suppressing Inflammation and Apoptosis. Kho MC; Park JH; Han BH; Tan R; Yoon JJ; Kim HY; Ahn YM; Lee YJ; Kang DG; Lee HS Nutrients; 2017 Apr; 9(4):. PubMed ID: 28420111 [TBL] [Abstract][Full Text] [Related]
28. Regulation of apolipoprotein A-1 and E gene expression in liver and intestine of nephrotic and pair-fed rats. Panduro A; Castrillón L; Pedraza-Chaverrí J; Vargas F; Ibarra-Rubio ME Nephron; 1993; 65(1):100-7. PubMed ID: 8413767 [TBL] [Abstract][Full Text] [Related]
29. Arginine vasopressin gene expression in rats with puromycin-induced nephrotic syndrome. Pyo HJ; Summer SN; Niederberger M; Kim JK; Schrier RW Am J Kidney Dis; 1995 Jan; 25(1):58-62. PubMed ID: 7810534 [TBL] [Abstract][Full Text] [Related]
30. Effects of low protein diet in puromycin aminonucleoside-induced nephrotic rats. Shibasaki T; Gomi H; Ishimoto F; Sakai O Nihon Jinzo Gakkai Shi; 1990 Aug; 32(8):871-5. PubMed ID: 2250404 [TBL] [Abstract][Full Text] [Related]
31. Decreased Excretion of Urinary Exosomal Aquaporin-2 in a Puromycin Aminonucleoside-Induced Nephrotic Syndrome Model. Abdeen A; Sonoda H; Kaito A; Oshikawa-Hori S; Fujimoto N; Ikeda M Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560242 [TBL] [Abstract][Full Text] [Related]
32. Actinomycin D blocks the hepatic functional albumin mRNA increase in aminonucleoside-nephrotic rats. Pedraza-Chaverri J; Huberman A Nephron; 1991; 59(4):648-50. PubMed ID: 1766506 [TBL] [Abstract][Full Text] [Related]
34. Protective effects of antithrombin on puromycin aminonucleoside nephrosis in rats. Yamashita J; Nakajima K; Ohno Y; Kaneshiro Y; Matsuo T; Tanaka H; Kaneko K Eur J Pharmacol; 2008 Jul; 589(1-3):239-44. PubMed ID: 18541230 [TBL] [Abstract][Full Text] [Related]
35. Compensatory increase in intestinal apolipoprotein A-IV mRNA levels in the experimental nephrotic rat. Seishima M; Noma A Metabolism; 1993 Oct; 42(10):1375-80. PubMed ID: 8412754 [TBL] [Abstract][Full Text] [Related]
36. Epithelial sodium channel (ENaC) subunit mRNA and protein expression in rats with puromycin aminonucleoside-induced nephrotic syndrome. Audigé A; Yu ZR; Frey BM; Uehlinger DE; Frey FJ; Vogt B Clin Sci (Lond); 2003 Apr; 104(4):389-95. PubMed ID: 12653683 [TBL] [Abstract][Full Text] [Related]
38. In vivo microvascular clearance of albumin in renal and extrarenal tissues in puromycin aminonucleoside (PAN) induced nephrotic syndrome. Oqvist BW; Rippe A; Tencer J; Rippe B Nephrol Dial Transplant; 1999 Aug; 14(8):1898-903. PubMed ID: 10462268 [TBL] [Abstract][Full Text] [Related]
39. Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside. Grond J; Weening JJ; Elema JD Lab Invest; 1984 Sep; 51(3):277-85. PubMed ID: 6471809 [TBL] [Abstract][Full Text] [Related]
40. The effect of a thromboxane A2 synthase inhibitor on the dyslipoproteinemia of an inbred rat strain with spontaneous age-related nephrotic syndrome. Tarugi P; Nicolini S; Albertazzi L; Marchi L; Calandra S; Salvati P Aging (Milano); 1994 Oct; 6(5):381-90. PubMed ID: 7893785 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]